ABCL vs SCHD
Abcellera Biologics Inc (ABCL) versus SCHD (SCHD) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
SCHD (SCHD) common stock.
Latest reported ABCL revenue for 2024-12-31 was $28.8M. Net income was -$162.9M. Revenue was down 24.2% from 2023-12-31 to 2024-12-31. ABCL currently screens at market cap $1.12B.
SCHD does not have a complete income-statement cache yet.
ABCL currently screens at market cap $1.12B. SCHD currently screens at market cap $0.
Not investment advice. Open the ABCL and SCHD stock pages for the full models.
Not investment advice.